LSV Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Sell |
577,700
-126,102
| -18% | -$2.74M | 0.03% | 362 |
|
|
2025
Q1 | $17.1M | Sell |
703,802
-73,322
| -9% | -$1.78M | 0.04% | 329 |
|
|
2024
Q4 | $16.2M | Sell |
777,124
-174,200
| -18% | -$3.64M | 0.04% | 344 |
|
|
2024
Q3 | $18.9M | Buy |
951,324
+77,424
| +9% | +$1.54M | 0.04% | 322 |
|
|
2024
Q2 | $13.5M | Sell |
873,900
-22,100
| -2% | -$342K | 0.03% | 393 |
|
|
2024
Q1 | $14.3M | Sell |
896,000
-334,700
| -27% | -$5.34M | 0.03% | 388 |
|
|
2023
Q4 | $20.7M | Sell |
1,230,700
-10,069
| -0.8% | -$169K | 0.05% | 332 |
|
|
2023
Q3 | $14.5M | Buy |
1,240,769
+253,100
| +26% | +$2.96M | 0.03% | 375 |
|
|
2023
Q2 | $13.3M | Buy |
987,669
+29,869
| +3% | +$401K | 0.03% | 384 |
|
|
2023
Q1 | $15.9M | Sell |
957,800
-59,671
| -6% | -$989K | 0.04% | 342 |
|
|
2022
Q4 | $18.9M | Sell |
1,017,471
-2,377,018
| -70% | -$44.2M | 0.04% | 314 |
|
|
2022
Q3 | $43.6M | Sell |
3,394,489
-635,188
| -16% | -$8.15M | 0.1% | 219 |
|
|
2022
Q2 | $28.2M | Buy |
4,029,677
+326,405
| +9% | +$2.29M | 0.06% | 262 |
|
|
2022
Q1 | $30.7M | Sell |
3,703,272
-348,797
| -9% | -$2.89M | 0.06% | 282 |
|
|
2021
Q4 | $27.4M | Sell |
4,052,069
-1,207,636
| -23% | -$8.18M | 0.05% | 315 |
|
|
2021
Q3 | $27.9M | Buy |
5,259,705
+1,019,389
| +24% | +$5.4M | 0.05% | 311 |
|
|
2021
Q2 | $24.4M | Buy |
4,240,316
+2,829,579
| +201% | +$16.3M | 0.04% | 350 |
|
|
2021
Q1 | $6.5M | Sell |
1,410,737
-82,400
| -6% | -$380K | 0.01% | 524 |
|
|
2020
Q4 | $4.99M | Sell |
1,493,137
-101,100
| -6% | -$338K | 0.01% | 558 |
|
|
2020
Q3 | $4.73M | Buy |
1,594,237
+1,424,544
| +839% | +$4.23M | 0.01% | 543 |
|
|
2020
Q2 | $783K | Buy |
+169,693
| New | +$783K | ﹤0.01% | 780 |
|